Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foshan Yuanli Biotechnology is a life sciences company headquartered in Foshan, China, specializing in the research, development, and manufacture of high-end biological reagents. The company primarily focuses on high-performance cell culture media and recombinant proteins, which serve as critical raw materials for the biopharmaceutical industry. By providing specialized media formulations and technical services, Foshan Yuanli supports the development and industrial-scale production of cell therapies and biologics. The company aims to provide localized, high-quality alternatives for upstream bioprocessing components in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foshan Yuanli Biotechnology.